Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Food and Drug Administration first approved some forms of GLP-1s for treating type 2 diabetes in 2005, its more recent approval as a weight loss drug, coupled with its increasing popularity, draws probable correlations between the drug and Gallup's obesity rate findings
Looking at a related medication gives some perspective
Further randomized clinical trials are needed to evaluate these preliminary findings and to determine the specific ways in which GLP-1s control cancer progression.
Common side effects include: Nausea Diarrhea Vomiting Decreased appetite Indigestion Constipation Weight loss Low blood sugar (particularly if youre on insulin therapy) Rare but serious side effects may include: Severe allergic reactions Impaired kidney function Gallbladder problems Medullary thyroid carcinoma (MTC) Do not take Victoza if you have a personal or family history of MTC, multiple endocrine neoplasia, or if you are allergic to liraglutide
US$ 29.83
US$ 26.06
US$ 23.99
US$ 25.32
US$ 27.62
US$ 28.34
US$ 20.10
